← Product Code [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB) · K131365 # T2 TIBIAL NAILING SYSTEM (K131365) _Stryker Trauma AG · HSB · Oct 10, 2013 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K131365 ## Device Facts - **Applicant:** Stryker Trauma AG - **Product Code:** [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB.md) - **Decision Date:** Oct 10, 2013 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3020 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compressed locked. The T2 Tibial Nailing System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following: - Open and closed tibial fractures - Pseudoarthodosis and correction osteotomy - Pathologic fractures, impending pathologic fractures, and tumor resections - Nonunion and malunion ## Device Story T2 Tibial Nailing System provides temporary stabilization for tibial fractures, nonunions, and malunions. System includes titanium intramedullary nails (proximal, standard, distal designs) and targeting device accessories. Used by surgeons in clinical settings via open or closed surgical techniques. Nails are statically, dynamically, or compression locked using associated screws and end caps. Targeting device facilitates accurate nail placement. System benefits patients by providing structural support for bone healing. No software or AI components involved. ## Clinical Evidence No clinical data. Substantial equivalence established via non-clinical laboratory testing including stiffness, bending load, transferable torque, impulse, drop, and cadaveric testing. ## Technological Characteristics Titanium intramedullary nails; proximal, standard, and distal designs. Includes targeting device accessories. Mechanical fixation via locking screws, compression screws, and end caps. Sterile. No software or electronic components. ## Regulatory Identification An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures. ## Predicate Devices - Titan Tibial Nail ([K003018](/device/K003018.md)) - Synthes Suprapatellar Insertion Instruments ([K111667](/device/K111667.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # 510(k) Summarv T2 Tibial Nailing Svstem Proprietary Name: Intramedullary Fixation Rod Common Name: Rod. Fixation. Intramedullary and Accessory 21 CFR Classification Name and Reference: \$888.3020 Proposed Regulatory Class: Class II OCT 1 0 2013 Product Codes: H&B For Information Contact: Estela Celi, RAC Regulatory Affairs Specialist Stryker Trauma AG 325 Corporate Drive Mahwah. NJ 07430 Phone: (201) 831-6461; Fax (201) 831-3461 Legally Marketed Devices to Which K003018 - Titan Tibial Nail K111667 - Synthes Suprapatellar Insertion Substantial Equivalence Is Claimed: Instruments Date Prepared: August 30, 2013 # Description This Traditional 510(k) submission is being supplied to the US FDA to include a modified targeter device and its components as Class II accessories as part of the Suprapatellar Instrument (SPI) System included in the T2 Tibial Nailing System, previously cleared under K003018 as the Titan Tibial Nail. The T2 Tibial Nailing System was determined substantially equivalent via 510/k) K003018 and included tibial nails and associated accessories such as locking screws. compression screws and end caps. There are three nail designs for the T2 Tibial Nail: Proximal. Standard, and Distal. These T2 tibial nails are fabricated from titanium and are available sterile. The T2 tibia targeter devices are intended to be used as part of the T2 Tibial Nailing System. In addition, this submission addresses a modification made to some components of the targeting device. ### Intended Use The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion, and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically, and compression locked. {1}------------------------------------------------ # Indications The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compressed locked. The T2 Tibial Nailing System is indicated for long bone fracture fixation. specifically tibial fracture fixation, which may include the following: - o Open and closed tibial fractures - · Pseudoarthodosis and correction osteotomy - Pathologic fractures, impending pathologic fractures, and tumor resections . - Nonunion and malunion . ## Summary of Technologies The subject device is substantially equivalent in intended use, materials and performance characteristics to the predicate devices. Inclusion of the targeter device and its components as accessories to the T2 Tibial Nailing System does not alter the device technology. # Non-Clinical Testing Non-clinical laboratory testing was performed on the targeting device and its components to determine substantial equivalence. Testing demonstrated that the subject targeter device is substantially equivalent to the predicate device currently cleared for marketing. The following testing was performed: - Stiffness Testing . - Bending Load o - o Transferable Torque of Connections - . Trunsferable Torque between Nail and Nail Adapter - 0 Impulse Test - . Drop Test - o Cadaveric Testing ## Clinical Testing Clinical testing was not required for this submission. ### Conclusion The T2 Tibial Nailing System and its components are substantially equivalent to the predicate devices identified in this premarket notification. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized symbol resembling an eagle or bird in flight, composed of three curved lines. The symbol is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. #### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G60 Silver Spring, MD 20993-0002 October 10, 2013 Stryker Trauma AG Ms. Estela Celi Regulatory Affairs Specialist 325 Corporate Drive Mahwah, New Jersey 07430 Re: K131365 Trade/Device Name: T2 Tibial Nailing System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: Class II Product Code: HSB Dated: September 13, 2013 Received: September 13, 2013 Dear Ms. Celi: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set {3}------------------------------------------------ # Page 2 - Ms. Estela Celi forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (30!) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincercly yours, # Erin | Keith for Mark Melkerson - Director - Division of Orthopedic Devices Office of Device Evaluation Center for Devices and - Radiological Health Enclosure {4}------------------------------------------------ ### Indications for Use KI31365 510(k) Number (if known): Device Name: T2 Tibial Nailing System Indications for Use: The T2 Tibial Nailing System is intended to provide temporary stabilization of various types of fractures, malunion and nonunion of the tibia. The nails are inserted using an opened or closed technique and can be statically, dynamically and compressed locked. The T2 Tibial Nailing System is indicated for long bone fracture fixation, specifically tibial fracture fixation, which may include the following: - Open and closed tibial fractures . - Pseudoarthodosis and correction osteotomy . - Pathologic fractures, impending pathologic fractures, and tumor resections � - Nonunion and malunion . Over-The-Counter Use Prescription Use X AND/OR (21 CFR 807 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Casey L. Hanley, Rh.D. Division of Orthopedic Devices --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K131365](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K131365) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com